Study Stopped
Insufficient enrollment
Prospective Analysis of "Genotype-phenotype" Correlations Observed in a Large Cohort of Patients With Hereditary Retinal Dystrophies - GEPHIRD
GEPHIRD
1 other identifier
observational
103
1 country
1
Brief Summary
This study will carry out a detailed descriptive analysis of a large population of patients with hereditary retinal dystrophies (HRD): clinical, paraclinical and genetic data. The information drawn from these analyzes will provide a better understanding of the pathophysiology of these rare diseases and this may ultimately impact the medical management of patients (targeted therapy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2018
CompletedFirst Posted
Study publicly available on registry
September 7, 2018
CompletedStudy Start
First participant enrolled
September 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2025
CompletedDecember 10, 2025
December 1, 2025
6.5 years
August 1, 2018
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Description of the phenotypic characteristics of patients with hereditary retinal dystrophies.
Phenotypic diagnosis of the type of retinal dystrophy based on all the examinations performed as part of the usual care and examinations added by the research (OCT-Angiography - Optical coherence tomography, and visual acuity with ETDRS scale : Early Treatment Diabetic Retinal Study, ETDRS).
Baseline
Description of the genotypic characteristics of patients with hereditary retinal dystrophies.
Determination of the genetic mutations responsible for retinal dystrophy in order to confirm the phenotypic diagnosis and identify correlation between the phenotypic and genotypic characteristics
Baseline
Study Arms (1)
Patients with suspicion of hereditary retinal dystrophy
Interventions
Optical coherence tomography angiography (OCT-A)
Visual acuity tested with ETDRS score (Early Treatment Diabetic Retinopathy Study)
Eligibility Criteria
Patients hospitalized for suspicion of hereditary retinal distrophy
You may qualify if:
- Patients hospitalized for suspicion of hereditary retinal dystrophy
- Benefiting as part of the care of a genetic analysis
You may not qualify if:
- \- Patient under a measure of legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation ophtalmologique Adolphe de Rothschild
Paris, 75019, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elise BOULANGER SCEMAMA
Fondation Ophtalmologique A. de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2018
First Posted
September 7, 2018
Study Start
September 14, 2018
Primary Completion
March 14, 2025
Study Completion
March 14, 2025
Last Updated
December 10, 2025
Record last verified: 2025-12